|
Dr. Ron Marks is a skilled and knowledgeable biostatistician and biomedical researcher, serving on the University of Florida faculty for 30 years in the Division of Biostatistics. He has an extensive background in the design, analysis and reporting of large-scale clinical trials and other research studies and has been a lead clinical trials consultant with a number of large pharmaceutical companies including Unilever, Braun, and Smith Kline Beecham. He has served as the Chairman of Smith Kline's Data Safety and Monitoring Committee for its worldwide herpes clinical trials program. Dr. Marks has been very active his entire career on many large clinical trials and other clinical research studies. His research has led to 130 scientific publications, a number of industry presentations and keynote addresses; he is routinely consulted for his insight regarding the state of the art in electronic clinical trials. Recently, he has become a leader in the Electronic Data Management Forum (EDMF), a leading group of technologists from 24 pharma companies and 18 associated businesses (such as CROs and EDC vendors). Ron has served in an administrative position as Director of the Division of Biostatistics at the University of Florida for 19 of his 30 years on the faculty. In 2004 Dr. Marks left the University of Florida and now devotes his time to building Clinipace and ensuring its proper direction in product design, trial execution, product commercialization and customer support. | 